Physician
Cardiology
Dr. Benjamin A. Steinberg, MD
|
|
Give Review
Benjamin Steinberg is an expert in the field of Cardiology. He researched medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a one of the best medicals schools. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine He has 2 awards "Joseph C. Greenfield Research Scholar Award for excellence in research" and "Research Fellowship". Benjamin Steinberg is a published MD. He has 44 papers published. The most current publication "Catheter Ablation of Atrial Fibrillation in U.S. Community Practice-Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)."
Publications
- Bucindolol hydrochloride in atrial fibrillation and concomitant heart failure.
- Catheter Ablation of Atrial Fibrillation in U.S. Community Practice-Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
- Contraindications to Anticoagulation Therapy and Eligibility for Novel Anticoagulants in Older Patients With Atrial Fibrillation.
- Heart rate is associated with progression of atrial fibrillation, independent of rhythm.
- Outcomes After Nonemergent Electrical Cardioversion for Atrial Arrhythmias.
- Periprocedural imaging and outcomes after catheter ablation of atrial fibrillation.
- Use and Outcomes Associated with Bridging During Anticoagulation Interruptions in Patients with Atrial Fibrillation: Findings from the Outcomes Registry for Better Inf...
- Non-vitamin-K oral anticoagulants reduce mortality, stroke and intracranial haemorrhage when compared with warfarin in randomised trials of patients with non-valvular ...
- Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012.
- Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial.
- Outcomes of Implantable Cardioverter-Defibrillator Use in Patients With Comorbidities: Results From a Combined Analysis of 4 Randomized Clinical Trials.
- Comparison of Safety of Sotalol Versus Amiodarone in Patients With Atrial Fibrillation and Coronary Artery Disease.
- Refined bleeding estimates in adults starting anticoagulants.
- Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry.
- Cost analysis of periprocedural imaging in patients undergoing catheter ablation for atrial fibrillation.
- Lack of Concordance Between Empirical Scores and Physician Assessments of Stroke and Bleeding Risk in Atrial Fibrillation: Results From the Outcomes Registry for Bette...
- Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: Results from the ROCKET AF trial.
- Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
- Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease.
- Risk assessment in atrial fibrillation: not all factors are created equal.
- Management of Postoperative Atrial Fibrillation and Subsequent Outcomes in Contemporary Patients Undergoing Cardiac Surgery: Insights From the Society of Thoracic Surg...
- Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies.
- Structure-function relationships of factor Xa inhibitors: implications for the practicing clinician.
- Evaluation and Management of the Atrial Fibrillation Patient: A Report From the Society of Cardiovascular Patient Care.
- Use and Associated Risks of Concomitant Aspirin Therapy With Oral Anticoagulation in Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better ...
- Comparative Effectiveness of Pharmacotherapies for Prevention of Atrial Fibrillation Following Coronary Artery Bypass Surgery.
- Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibri...
- Left Atrial Remodeling: Shape Before Size?
- Dose-adjusted warfarin: writing the prescription is only the beginning.
- Treatment pathways and quality improvement for patients with acute myocardial infarction at a tertiary care center.
- Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease.
- Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: safety, tolerability, and therapeutic potential.
- Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database.
- Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysi...
- An annual, prospective, international study of outpatients with cardiovascular disease or risk factors: design and methods of the CardioMonitor registry.
- Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy.
- Are statins being underdosed in clinical practice? Data from TACTICS-TIMI 18.
- Magnetocardiogram recordings in a nonshielded environment--reproducibility and ischemia detection.
- Anticoagulation in atrial fibrillation.
- Missed diagnosis of the diagnosis codes: comparison of International Classification of Diseases, 9th Revision coding and ST- versus non-ST-elevation myocardial infarct...
- Is coding for myocardial infarction more accurate now that coding descriptions have been clarified to distinguish ST-elevation myocardial infarction from non-ST elevat...
- Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery byp...
- Safety of bivalirudin during percutaneous coronary interventions in patients with abnormal renal function.
Schools
Johns Hopkins University School of Medicine
Doctors Specialties
- Internal Medicine
- Cardiology
Accepted Insurances
Awards
- Joseph C. Greenfield Research Scholar Award for excellence in research
- Research Fellowship
Education
-
Duke University Hospital -
Duke University -
Johns Hopkins University -
Johns Hopkins University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Jonathan Chrispin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rehan Qayyum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anca-Magdalena Frujinoiu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mustafa Abdulmahdi, MD |
|
|
Dr. Dorothy M. Seay, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Terry Watnick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Meyerson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan Dubin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shazia F. Mehmood, MD |
|
|
Dr. Edward G. Lakatta, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gautam V. Ramani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oscar H. Cingolani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neville F. Mistry, MD
This Doctor is OpenDoctor Recommended.
|